CAMAF Member Option Guides & Info

Bin Them or Bank Them? [Stem Cell Brochure]

Issue link: https://www.hub.camaf.co.za/i/928413

Contents of this Issue

Navigation

Page 8 of 15

9 BlOOd cancers Acute Lymphoblastic Leukaemia (ALL) Acute Myeloid Leukaemia (AML) Chronic Myeloid Leukaemia (CML) Myelodysplastic Syndrome (MDS) Multiple Myeloma Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Bone marrow failure syndromes Severe Aplastic Anaemia, Unspecified Fanconi Anaemia BlOOd disOrders Sickle Cell Disease Thalassemia immUnOdeficiencies Severe Combined Immune Deficiency (SCID) Wiskott-Aldrich Syndrome inherited metaBOlic disOrders Hurler Disease (MPS type IH) Osteopetrosis Adrenoleukodystrophy Krabbe Disease aUtOimmUne diseases Systemic Lupus (SLE) Umbilical cord blood approved stem cell therapies first used Cord blood stem cells were first successfully transplanted in 1988, and now it is used to treat over 80 blood-related diseases. UmBilical cOrd BlOOd research Cerebral palsy Autism Neonatal oxygen deprivation Acquired hearing loss Encephalopathy (neonatal) Hypoplastic left heart syndrome Stroke (pre/peri-natal) Traumatic brain injury Type 1 Diabetes clinical trials where children use their own (autologous) cord blood stem cells Alzheimer's disease Bronchopulmonary dysplasia Cartilage repair Cerebral palsy Critical limb ischemia Global development delay Graft versus host diseases HIV Fertility Intraventricular haemorrhage Liver cisshosis Neurodegenerative disorders Stroke Sweat gland regeneration Type 1 Diabetes clinical trials where children use donor (allogeneic) cord blood stem cells

Articles in this issue

view archives of CAMAF Member Option Guides & Info - Bin Them or Bank Them? [Stem Cell Brochure]